Cathie Wood Loads Up $23M In Gene-Editing Company’s Shares As They Slump 10% In A Month
Cathie Wood-led Ark Investment Management on Friday raised its stake in clinical stage genetics medicine company Verve Therapeutics Inc (NASDAQ: VERV) via two of its exchange-traded funds.